Eli Lilly and Co Analyst Ratings
NVIDIA Analyst Ratings
Meta Platforms Analyst Ratings
Alphabet Analyst Ratings
Goldman Sachs Adjusts Price Target on Eli Lilly & Co. to $793 From $785, Maintains Neutral Rating
Eli Lilly and Co Analyst Ratings
Evercore ISI Adjusts Price Target on Microsoft to $485 From $500
NVIDIA Analyst Ratings
Apple Analyst Ratings
Meta Platforms Analyst Ratings
Canaccord Genuity Adjusts Price Target on Alphabet to $220 From $210, Keeps Buy Rating
Canaccord Genuity Adjusts Price Target on Meta Platforms to $600 From $575, Keeps Buy Rating
Canaccord Genuity Adjusts Price Target on Amazon.com to $230 From $215, Maintains Buy Rating
Morgan Stanley Adjusts Price Target on NVIDIA to $144 From $116, Maintains Overweight Rating
Amazon.com Analyst Ratings
Alphabet Analyst Ratings
Google Downgraded by Rosenblatt on Multiple Areas of Transition Risk, Including AI
Oppenheimer Adjusts Price Target on Apple to $250 From $200
Wells Fargo Adjusts Price Target on Amazon.com to $239 From $234, Maintains Overweight Rating
Truist Adjusts Price Target on NVIDIA to $140 From $128.80, Maintains Buy Rating